TRT May Reduce Mortality Without Improving CV Health in Diabetes
In a study, reduced mortality was found among TRT users with type 2 diabetes after adjustment for cardiovascular risk factors.
View ArticleAuto-Injected Testosterone May Address Some TRT Shortcomings
Single-dose disposable auto injector approved for once-weekly subcutaneous administration of testosterone may cut down on potential problems associated with other options.
View ArticleTestosterone Therapy Not Linked to Higher Cardiovascular Risks
In a recent meta-analysis, testosterone therapy was not associated with major or minor adverse cardiovascular events.
View ArticleStudy: TRT May Improve Mobility, But Not Fall Risk
In a study, older men with difficulty walking or climbing stairs reported better physical function after testosterone therapy.
View ArticleTestosterone Therapy May Ease Depressive Symptoms
Meta-analysis suggests that testosterone treatment enhances mood in hypogonadal and eugonadal men.
View ArticleXyosted Now Available for Treatment of Testosterone Deficiency
Prior to starting Xyosted, the patient's baseline cardiovascular risk should be considered and blood pressure should be adequately controlled.
View ArticleStudy: Testosterone Replacement Does Not Increase DVT Risk
In a study, the rate of deep vein thrombosis in treated hypogonadal men was just 0.8% over 2 years of follow-up.
View ArticleHypogonadism Predicts Varicocele Repair
Hypogonadism and serum testosterone evaluation nearly doubled the odds a man would undergo varicocelectomy.
View ArticleMedical Marketing Has Increased in Past 20 Years
Considerable increase seen from 1997 through 2016, especially in direct-to-consumer advertising
View ArticleTestosterone Use Remains High Among Men With Coronary Artery Disease
Despite research suggesting that there may be increased cardiovascular risk from off-label prescription testosterone use, usage in men with coronary artery disease remains higher than in men without...
View Article
